Boron and Profen drug interactions - a phase IV clinical study of FDA data


Drug interactions are reported among 19 people who take Boron and Profen. Common interactions include urinary tract infection among females, and insomnia among males.

The phase IV clinical study analyzes what interactions people who take Boron and Profen have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 28, 2023

19 people who take Boron and Profen together, and have interactions are studied.

What is Boron?

Boron has active ingredients of boron. Currently, eHealthMe is studying from 401 Boron users.

What is Profen?

Profen has active ingredients of ibuprofen. It is used in pain. Currently, eHealthMe is studying from 231,318 Profen users.

Number of Boron and Profen reports submitted per year:

Boron and Profen drug interactions.

Common Boron and Profen drug interactions by gender *:


  1. Urinary tract infection
  2. Blood pressure increased
  3. Confusional state
  4. Diarrhoea
  5. Drug ineffective
  6. Hallucination
  7. Headache
  8. Abdominal pain upper
  9. Anxiety
  10. Coma


  1. Insomnia
  2. Drug ineffective
  3. Depression
  4. Disturbance in attention
  5. Dizziness
  6. Drug effect decreased
  7. Drug half-life reduced
  8. Fear
  9. Flushing
  10. Hyperhidrosis

Common Boron and Profen drug interactions by age *:










  1. Confusional state
  2. Depression
  3. Disturbance in attention
  4. Drug ineffective
  5. Fear
  6. Insomnia
  7. Memory impairment
  8. Sluggishness


  1. Anxiety
  2. Drug ineffective
  3. Muscle swelling


  1. Drug effect decreased
  2. Dyspepsia
  3. Feeling jittery
  4. Headache
  5. Malaise
  6. Nasopharyngitis
  7. Nausea
  8. Paraesthesia
  9. Stomatitis
  10. Vomiting


  1. Insomnia
  2. Chronic kidney disease
  3. Blood pressure increased
  4. Dizziness
  5. Drug effect decreased
  6. Drug half-life reduced
  7. Flushing
  8. Headache
  9. Hyperhidrosis
  10. Hyperparathyroidism secondary

Common conditions people have *:

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 8 people, 42.11%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 7 people, 36.84%
  3. Infection: 2 people, 10.53%
  4. Cough: 2 people, 10.53%
  5. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 10.53%
  6. Hypokalemia (low potassium): 1 person, 5.26%
  7. Back Pain: 1 person, 5.26%
  8. Depression: 1 person, 5.26%
  9. Gout (uric acid crystals building up in the body): 1 person, 5.26%
  10. High Blood Pressure: 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Boron and Profen?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

Drug side effects by duration, gender and age:

Common Boron drug interactions:

Browse interactions between Boron and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Profen drug interactions:

Browse interactions between Profen and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on boron and ibuprofen (the active ingredients of Boron and Profen, respectively), and Boron and Profen (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Boron and Profen.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: